Urinary Tract Infection Prevention and Treatment

Semin Nephrol. 2023 Sep;43(5):151468. doi: 10.1016/j.semnephrol.2023.151468. Epub 2024 Feb 24.

Abstract

Urinary tract infections are the most common bacterial infections encountered by health care professionals. In women, the lifetime incidence of urinary tract infections may be up to 40% to 50%, of whom a further 40% may have recurrent infections. Urinary tract infections are associated with significant morbidity and potential mortality-they may be complicated by frequent recurrences, kidney damage, sepsis, and preterm birth, as well as collateral damage of antimicrobial use, which includes Clostridium difficile colitis and selection of drug-resistant organisms. There are personal costs such as reduced quality of life in patients affected by recurrent urinary tract infections, and societal impacts resulting from absenteeism and health care costs. In this review, we discuss the definitions and classifications, pathogenesis, and current principles of management and prevention of urinary tract infections. Semin Nephrol 43:x-xx © 2023 Elsevier Inc. All rights reserved.

Keywords: Urinary tract infections; management; pathogenesis; urosepsis.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Infections*
  • Female
  • Humans
  • Infant, Newborn
  • Premature Birth*
  • Quality of Life
  • Sepsis*
  • Urinary Tract Infections* / drug therapy
  • Urinary Tract Infections* / prevention & control

Substances

  • Anti-Bacterial Agents